News
Legislative/Advocacy
CMS Proposes New Coverage for Breakthrough Technologies
October 26, 2020
WASHINGTON, DC – As shared in the Sept. 9 edition of AAH Insider, CMS published a proposed rule titled: Medicare Coverage of Innovative Technology and the Definition of “Reasonable and Necessary”. In this rule, CMS is proposing to esta
News
Legislative/Advocacy
Provider Relief Fund Distribution Details
October 26, 2020
WASHINGTON, DC – HHS is accepting applications for the $20 billion Phase 3 General Distribution under the Provider Relief Fund (PRF) until November 6. All DMEPOS suppliers that have done business with Medicare or Medicaid are eligible to apply
News
Legislative/Advocacy
Stand Up for Homecare Virtual Happy Hour
October 17, 2020
WASHINGTON, DC – COVID-19 may keep advocates from getting together in person, but officials at the American Association for Homecare (AAHomecare) are committed to bring people together via the first-ever virtual Stand Up for Homecare event for
News
Legislative/Advocacy
HHS Shares Details on $20 Billion Phase 3 Provider Relief
October 11, 2020
WASHINGTON, DC – HHS opened the $20 billion Phase 3 General Distribution under the Provider Relief Fund (PRF) on Monday, October 5th. Applications for Phase 3 are available to health care providers, including DMEPOS companies that have alre
News
Legislative/Advocacy
Medical Supplies Council Launches Ostomy Effort, Makes Progress with Woundcare and Incontinence Initiatives
October 11, 2020
WASHINGTON, DC – The American Association for Homecare Medical Supplies Council is working diligently to tackle issues and pursue opportunities in the disposable medical supplies space. At their recent September 24th virtual meeting, the group
News
Legislative/Advocacy
Providers Can Apply for Phase 3 General Distribution Funding Beginning Oct. 5 Through Nov. 6, 2020
October 4, 2020
WASHINGTON, D.C. – Yesterday, HHS announced additional funding for health care providers through the Provider Relief Fund. Providers that already received their relief of 2% of net patient revenue through the $50B Phase 1 & 2 of General Dis